Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
NCT07589595
- Conditions
- Alzheimer Disease, Amyloid, Basal Ganglia Diseases, +17 more
- Locations
-
- TrialSphere Corp Chandler, Arizona, United States
- HonorHealth Research Institute Scottsdale, Arizona, United States
- Profound Research LLC Carlsbad, California, United States
- Irvine Clinical Research Irvine, California, United States